Search research articles
Contact Us
Filters
Showing results (161-170 of 174) with videos related to
Page
of 18
Sort By:
BJS Open
|
May 29, 2026
Cancer vaccines: comprehensive review
Rachael E Clifford, Nichola Manu, Qian Yang, et al.
Behavior Research Methods
|
September 25, 2024
Assessing computational reproducibility in Behavior Research Methods
David A Ellis, John Towse, Olivia Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 18, 2018
Patritumab with Cetuximab plus Platinum-Containing Therapy in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: An Open-Label, Phase Ib Study
Magnus T Dillon, Lorna Grove, Kate L Newbold, et al.
Cancer Investigation
|
March 5, 2008
A pilot study of predictive markers of chemotherapy-related amenorrhea among premenopausal women with early stage breast cancer
Carey Anders, P Kelly Marcom, Bercedis Peterson, et al.
Behavior Research Methods
|
September 25, 2020
Development of an Offline-Friend Addiction Questionnaire (O-FAQ): Are most people really social addicts?
Liam P Satchell, Dean Fido, Craig A Harper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 18, 2008
Phase I pharmacokinetic and pharmacodynamic study of LAQ824, a hydroxamate histone deacetylase inhibitor with a heat shock protein-90 inhibitory profile, in patients with advanced solid tumors
Johann S de Bono, Rebecca Kristeleit, Anthony Tolcher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 4, 2010
Phase I trial of the irreversible EGFR and HER2 kinase inhibitor BIBW 2992 in patients with advanced solid tumors
Timothy A Yap, Laura Vidal, Jan Adam, et al.
Cancers
|
December 10, 2021
Systemic Anti-Cancer Therapy and Metastatic Cancer Are Independent Mortality Risk Factors during Two UK Waves of the COVID-19 Pandemic at University College London Hospital
Yien Ning Sophia Wong, Christopher C T Sng, Diego Ottaviani, et al.
Cancers
|
December 30, 2025
Specialist Neurology Involvement and Impact in Immune Checkpoint Inhibitor-Related Neurotoxicity: Experience in a Unified Healthcare System
Benjamin Schroeder, Prakrit Prasad, Ope Gbadegesin, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 30, 2025
Uveal Melanoma UK national guidelines: 2023 update
Thomas J Carter, Jack Broadfoot, Sarah E Coupland, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 174) with videos related to
Sort By:
Page
of 18
BJS Open
|
May 29, 2026
Cancer vaccines: comprehensive review
Rachael E Clifford, Nichola Manu, Qian Yang, et al.
Behavior Research Methods
|
September 25, 2024
Assessing computational reproducibility in Behavior Research Methods
David A Ellis, John Towse, Olivia Brown, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 18, 2018
Patritumab with Cetuximab plus Platinum-Containing Therapy in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: An Open-Label, Phase Ib Study
Magnus T Dillon, Lorna Grove, Kate L Newbold, et al.
Cancer Investigation
|
March 5, 2008
A pilot study of predictive markers of chemotherapy-related amenorrhea among premenopausal women with early stage breast cancer
Carey Anders, P Kelly Marcom, Bercedis Peterson, et al.
Behavior Research Methods
|
September 25, 2020
Development of an Offline-Friend Addiction Questionnaire (O-FAQ): Are most people really social addicts?
Liam P Satchell, Dean Fido, Craig A Harper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 18, 2008
Phase I pharmacokinetic and pharmacodynamic study of LAQ824, a hydroxamate histone deacetylase inhibitor with a heat shock protein-90 inhibitory profile, in patients with advanced solid tumors
Johann S de Bono, Rebecca Kristeleit, Anthony Tolcher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 4, 2010
Phase I trial of the irreversible EGFR and HER2 kinase inhibitor BIBW 2992 in patients with advanced solid tumors
Timothy A Yap, Laura Vidal, Jan Adam, et al.
Cancers
|
December 10, 2021
Systemic Anti-Cancer Therapy and Metastatic Cancer Are Independent Mortality Risk Factors during Two UK Waves of the COVID-19 Pandemic at University College London Hospital
Yien Ning Sophia Wong, Christopher C T Sng, Diego Ottaviani, et al.
Cancers
|
December 30, 2025
Specialist Neurology Involvement and Impact in Immune Checkpoint Inhibitor-Related Neurotoxicity: Experience in a Unified Healthcare System
Benjamin Schroeder, Prakrit Prasad, Ope Gbadegesin, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 30, 2025
Uveal Melanoma UK national guidelines: 2023 update
Thomas J Carter, Jack Broadfoot, Sarah E Coupland, et al.
Page
of 18